MedPath
HSA Approval

MABRON INJECTION 100 mg/2 ml

SIN08740P

MABRON INJECTION 100 mg/2 ml

MABRON INJECTION 100 mg/2 ml

June 6, 1996

MEDOCHEMIE SINGAPORE PTE. LTD.

MEDOCHEMIE SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMEDOCHEMIE SINGAPORE PTE. LTD.
Licence HolderMEDOCHEMIE SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS, SUBCUTANEOUS, INTRAMUSCULAR

Medical Information

N02AX02

tramadol

Manufacturer Information

MEDOCHEMIE SINGAPORE PTE. LTD.

Medochemie Ltd – Facility Ampoules Inj.

Active Ingredients

TRAMADOL 88 MG/ 2ML EQV TRAMADOL HCl

100 mg/2 ml

Tramadol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MABRON INJECTION 100 mg/2 ml - HSA Approval | MedPath